Literature DB >> 18641965

[Radiotherapy in prostate cancer].

U Ganswindt1, C Belka.   

Abstract

Radiotherapy is a well-accepted treatment modality for patients with localised prostate cancer. Provided that radiotherapy is applied with a sufficient radiation dose, it is as effective as radical prostatectomy. Different radiation modalities are available (interstitial brachytherapy, external beam radiotherapy or a combination of both). Various new developments will further increase the value of radiation-based approaches. In this regard, a wider use of intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) will result in higher treatment doses with even lower toxicity rates. Combinations of radiotherapy and hormonal ablation improve local control rates in defined groups of patients. After prostatectomy with positive surgical margins, adjuvant radiotherapy improves disease-free survival rates; in cases of local relapse, salvage radiotherapy is the only potentially curative treatment approach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641965     DOI: 10.1007/s00120-008-1846-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  27 in total

1.  A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.

Authors:  Koichiro Akakura; Hiroyoshi Suzuki; Tomohiko Ichikawa; Hiroyuki Fujimoto; Osamu Maeda; Michiyuki Usami; Daisaku Hirano; Yukie Takimoto; Toshiyuki Kamoto; Osamu Ogawa; Yoshiteru Sumiyoshi; Jun Shimazaki; Tadao Kakizoe
Journal:  Jpn J Clin Oncol       Date:  2006-11-02       Impact factor: 3.019

2.  The Titanic and the Iceberg: prostate proton therapy and health care economics.

Authors:  Anthony L Zietman
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

Review 3.  70 Gy or more: which dose for which prostate cancer?

Authors:  U Ganswindt; F Paulsen; A G Anastasiadis; A Stenzl; M Bamberg; C Belka
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-11       Impact factor: 4.553

4.  Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.

Authors:  Sophie G Fletcher; Stacey E Mills; Mark E Smolkin; Dan Theodorescu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-11       Impact factor: 7.038

5.  Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

Authors:  Jonathan B Ashman; Michael J Zelefsky; Margie S Hunt; Steven A Leibel; Zvi Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-01       Impact factor: 7.038

6.  Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.

Authors:  Theodorus H Van der Kwast; Michel Bolla; Hein Van Poppel; Paul Van Cangh; Kris Vekemans; Luigi Da Pozzo; Jean-Francois Bosset; Karl H Kurth; Fritz H Schröder; Laurence Collette
Journal:  J Clin Oncol       Date:  2007-09-20       Impact factor: 44.544

7.  Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Authors:  Michel Bolla; Laurence Collette; Léo Blank; Padraig Warde; Jean Bernard Dubois; René-Olivier Mirimanoff; Guy Storme; Jacques Bernier; Abraham Kuten; Cora Sternberg; Johan Mattelaer; José Lopez Torecilla; J Rafael Pfeffer; Carmel Lino Cutajar; Alfredo Zurlo; Marianne Pierart
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

8.  Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience.

Authors:  John E Sylvester; John C Blasko; Peter D Grimm; Robert Meier; Judith A Malmgren
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

9.  Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate?

Authors:  Andre Konski; William Speier; Alexandra Hanlon; J Robert Beck; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

10.  Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

Authors:  Patrick A Kupelian; Louis Potters; Deepak Khuntia; Jay P Ciezki; Chandana A Reddy; Alwyn M Reuther; Thomas P Carlson; Eric A Klein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

View more
  1 in total

1.  Choline PET based dose-painting in prostate cancer--modelling of dose effects.

Authors:  Maximilian Niyazi; Peter Bartenstein; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2010-03-18       Impact factor: 3.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.